Dr. Reddy’s To Invest ₹700 Cr In Biosimilars and API - GV Prasad On Investments & AI
1.9 هزار بار بازدید -
9 ماه پیش
-
Dr. Reddy’s plans to invest
Dr. Reddy’s plans to invest ₹700 Cr into capacity expansion of biosimilars and Active Pharmaceutical Ingredients. GV Prasad, Co-chairman and Managing Director of Dr. Reddy Laboratories shares his insights on future investments and artificial intelligence. We have seen how AI has reduced the amount of experimentation we need to do, bring more precision to our work, and give us ideas that normal human beings wouldn’t have thought about. He also said how they are using machine learning to understand scaleups. For information watch this interview.
#drreddys #davos #worldeconomicforum
Moneycontrol is India's leading financial and business portal with in-depth market coverage, analysis, expert opinions, and a gamut of financial tools.
A part of Network18, moneycontrol.com is the most influential destination for stock market news and advice, business news, and news about the Indian and global economy.
Subscribe: https://bit.ly/moneycontrolyoutube
Follow us:
Visit https://www.moneycontrol.com/
Facebook: Facebook: moneycontrol
Twitter: Twitter: moneycontrolcom
Instagram: Instagram: moneycontrolcom
#drreddys #davos #worldeconomicforum
Moneycontrol is India's leading financial and business portal with in-depth market coverage, analysis, expert opinions, and a gamut of financial tools.
A part of Network18, moneycontrol.com is the most influential destination for stock market news and advice, business news, and news about the Indian and global economy.
Subscribe: https://bit.ly/moneycontrolyoutube
Follow us:
Visit https://www.moneycontrol.com/
Facebook: Facebook: moneycontrol
Twitter: Twitter: moneycontrolcom
Instagram: Instagram: moneycontrolcom
9 ماه پیش
در تاریخ 1402/10/25 منتشر شده
است.
1,930
بـار بازدید شده